X4 Pharmaceuticals to Present at Canaccord Genuity’s 42nd Annual Growth Conference Aug 8, 2022 04:05PM
X4 Pharmaceuticals (XFOR) PT Lowered to $10 at Canaccord Genuity Apr 5, 2022 09:22AM
X4 Pharmaceuticals to Present at April Investor Conferences Apr 4, 2022 08:05AM
X4 Pharmaceuticals to Participate at Canaccord Genuity’s Virtual 41st Annual Growth Conference Aug 4, 2021 04:01PM
X4 Pharmaceuticals Announces Key Enrollment Milestone Achievements in Ongoing Mavorixafor Clinical Trials and Reports Second Quarter Financial Results Aug 3, 2021 08:00AM


Aug 10, 2020 05:07PM X4 Pharmaceuticals to Present and Participate in the Canaccord Genuity’s 40th Annual Growth Conference
Nov 26, 2019 08:31AM X4 Pharmaceuticals (XFOR) Prices Offering at $12/Share w/Warrants
Nov 26, 2019 08:30AM X4 Pharmaceuticals Prices $65 Million Public Offering of Common Stock and Class B Warrants
Nov 25, 2019 04:01PM X4 Pharmaceuticals (XFOR) to Offer Common Stock and Warrants
Nov 25, 2019 04:00PM X4 Pharmaceuticals Announces Proposed Public Offering
Jul 24, 2019 08:30AM X4 Pharmaceuticals to Attend Two Upcoming Investor Conferences
May 21, 2019 05:19AM Canaccord Genuity Starts X4 Pharmaceuticals (XFOR) at Buy
Apr 12, 2019 09:33AM X4 Pharmaceuticals (XFOR) Prices 5.7M Shares at $11 w/Warrants
Apr 12, 2019 09:29AM X4 Pharmaceuticals Prices $85.8 Million Public Offering of Common Stock and Class A Warrants
Apr 11, 2019 04:01PM X4 Pharmaceuticals Inc. (XFOR) Announces Proposed Common Share and Class A Warrants Offering
Apr 11, 2019 04:00PM X4 Pharmaceuticals Announces Proposed Public Offering of Common Stock and Class A Warrants